FENTANYL
Cerebral Edema
University of FloridaSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Cerebral Edema cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Sodium Aescinate The Second Hospital of Hebei Medical University | Phase 4 | BB |
Conivaptan Jesse Corry | Phase 2 | B |
DEXAMETHASONE Jon Pérez Bárcena | Phase 3 | B |
Famotidine University of Florida | Phase 2 | B |
Ketorolac Tromethamine University of Florida | Phase 2 | B |
View all 18 →
Same molecule, other indications
FENTANYL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →